Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Historical Holders from Q1 2023 to Q3 2025

Symbol
RNAC on Nasdaq
CUSIP
816212302
Type / Class
Equity / COMMON STOCK
Shares outstanding
26M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
5.97M
Holdings value
$60.9M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
65
Number of buys
26
Number of sells
-23
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRINGER TIMOTHY A 36.9% +0.27% $102M $226K 9.56M +0.22% Timothy A. Springer Jan 13, 2025
FMR LLC 8.3% -12.2% $22M -$2.73M 2.16M -11% FMR LLC Sep 30, 2025
JPMORGAN CHASE & CO 6.1% $17.9M 1.68M JPMORGAN CHASE & CO. Mar 31, 2025

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5.97M $60.9M -$4.44M $10.22 65
2025 Q2 6.4M $66.5M -$2.05M $10.39 65
2025 Q1 6.58M $86.7M -$755K $13.18 68
2024 Q4 6.67M $119M -$2.7M $17.91 63
2024 Q3 6.87M $110M +$42.9M $16.12 61
2024 Q2 3.27M $88.3M +$88.1M $27.01 59
2024 Q1 1.86K $1.16K +$1.16K $0.64 4
2023 Q4 0 $0 -$1.27K 0
2023 Q3 1.2K $1.27K $0 $1.06 1
2023 Q2 1.2K $1.34K $0 $1.12 1
2023 Q1 1.2K $1.67K $0 $1.39 1